Unibest 优贝德
← Back to patent-cliff list

CAS 2229909-39-9

(1R,2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexyl (3E)-2-(acetyloxy)-3-(methoxyimino)-3-phenylpropanoate

Codes:(II)140605-33-a

Application context (from source-drug indications)

膀胱癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)头颈癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)头颈部鳞状细胞癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)实体瘤多西他赛纳米胶束 (Samyang Biopharmaceuticals)

Source drugs (routes using this intermediate)

DrugTierExpiry
多西他赛纳米胶束 (Samyang Biopharmaceuticals)Docetaxel polymeric micelle (Samyang Biopharmaceuticals)Tier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

(1R,2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexyl (3Z)-3-(methoxyimino)-3-phenylpropanoate→(1R,2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexyl (3E)-2-(acetyloxy)-3-(methoxyimino)-3-phenylpropanoate→(1R,2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexyl (3E)-3-(methoxyimino)-3-phenyl-2-[(trifluoromethanesulfonyl)oxy]propanoate→(1R,2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexyl (2S,3E)-2-hydroxy-3-(methoxyimino)-3-phenylpropanoate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.